Directed Evolution of a Novel Adeno-associated Virus (AAV) Vector That Crosses the Seizure-compromised Blood–Brain Barrier (BBB)
Open Access
- 1 March 2010
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 18 (3) , 570-578
- https://doi.org/10.1038/mt.2009.292
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Neurological Disorders and Stroke (NS059518)
- International Rett Syndrome Foundation (NS059518)
This publication has 29 references indexed in Scilit:
- Adeno-Associated Virus-Mediated Gene Transfer to Nonhuman Primate Liver Can Elicit Destructive Transgene-Specific T Cell ResponsesHuman Gene Therapy, 2009
- Mannitol-facilitated CNS entry of rAAV2 vector significantly delayed the neurological disease progression in MPS IIIB miceGene Therapy, 2009
- Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor NeuronsMolecular Therapy, 2009
- Successful Expansion but Not Complete Restriction of Tropism of Adeno-Associated Virus by In Vivo Biopanning of Random Virus Display Peptide LibrariesPLOS ONE, 2009
- A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selectionProceedings of the National Academy of Sciences, 2009
- Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytesNature Biotechnology, 2008
- Brain Regional Differences in the Effect of Ethanol on GABA Release from Presynaptic TerminalsThe Journal of Pharmacology and Experimental Therapeutics, 2008
- In Vitro and In Vivo Gene Therapy Vector Evolution via Multispecies Interbreeding and Retargeting of Adeno-Associated VirusesJournal of Virology, 2008
- In Vivo and In Vitro Effects of Pilocarpine: Relevance to IctogenesisEpilepsia, 2007
- Single Amino Acid Changes Can Influence Titer, Heparin Binding, and Tissue Tropism in Different Adeno-Associated Virus SerotypesJournal of Virology, 2006